Skip to content

Who We Are

A site management organization built by people who have done the work.

Premier Bioservices, LLC manages clinical studies across a network of clinics, practices, and health systems, and staffs the remote clinical follow-up that keeps those studies on schedule. Our leadership combines academic research operations with healthcare finance — study design and study economics, in the same room.

Our operating model

We manage studies across multiple sites rather than hosting them at one.

Premier Bioservices does not concentrate studies at a single facility. We activate and manage them across a network of clinics, physician practices, and health systems, placing each protocol where the right patient population and the right investigator experience already exist.

That decision is deliberate. Published research is consistent that trials distributed across more sites enroll faster, and that participant travel burden is a primary suppressor of both recruitment and visit compliance. Concentrating a study in one building optimizes for our convenience and against the patient's.

Around the network we run a centralized operating layer — feasibility, contracting, regulatory, training, monitoring, and reporting — plus a team of clinical nurses conducting remote and in-home follow-up. Sites see patients. We handle everything that makes seeing those patients possible.

01

Honest feasibility

We would rather tell a sponsor the network cannot deliver an enrollment target than accept the study and miss it. Predictability is the entire value of an SMO.

02

The provider is the point

A provider who feels buried by their first study will never run a second. Removing administrative weight is not a courtesy, it is the business model.

03

Documented, not asserted

Under ICH E6(R3), oversight that is not visible in an action log does not exist. We build the record as the work happens rather than reconstructing it before an inspection.

04

Meet the patient where they are

Telehealth, in-home visits, and remotely captured data are not conveniences. For a wound care patient with limited mobility, they are the difference between participating and declining.

Leadership

Study design and study economics, in the same room.

Premier Bioservices is led by two people whose backgrounds cover the two places site-level research most often fails: protocol and regulatory execution, and the money.

Jesus Monico, PhD, MPH

Research & Scientific Operations

Dr. Monico brings extensive experience in academic medical centre research operations, spanning histotechnology, biobanking, clinical research design and protocol development, and the regulatory process governing research studies.

That combination matters at the site level. Protocol feasibility, specimen handling logistics, and regulatory submission are the three places a study most often stalls before the first patient is enrolled, and they are the places he has spent his career.

Education

  • PhD, Clinical Health Sciences — University of Mississippi Medical Center
  • MS, Biomedical Sciences — University of Mississippi Medical Center
  • MPH — Tulane University
  • BS, Microbiology — Louisiana State University
  • BS, Biological Sciences — University of New Orleans

Professional affiliations

  • International Society for Biological and Environmental Repositories (ISBER)
  • Association of Clinical Research Professionals (ACRP)

Walt Rogers

Business & Financial Operations

Walt Rogers has more than twenty years in healthcare finance, including service as Chief Financial Officer for acute care hospitals, physician groups, and related healthcare entities.

Research economics are where most site-level programs quietly fail. Budgets that do not cover the protocol's real requirements, coverage analysis exposure that nobody reviewed, and invoicing that nobody owns turn productive studies into losses. He negotiates the budgets and runs the financial side of every engagement so that does not happen.

Education

  • BBA, Information Systems — Mississippi State University
  • Mississippi School for Mathematics and Science

The wider team

The people who actually run your study.

Beyond leadership, engagements are staffed by the functional roles a protocol requires. Composition is scoped to the study rather than fixed.

Clinical nurse monitors

Licensed nurses conducting telehealth and in-home visits, reviewing remotely captured data, running retention contact, and escalating safety signals to the investigator on a defined pathway.

Clinical research coordinators

On-site or embedded coordinators running visits, source documentation, specimen handling, and day-to-day protocol execution at each location.

Regulatory specialists

IRB submissions and amendments, essential document collection, delegation logs, training records, and inspection readiness across the network.

Investigators and sub-investigators

Network physicians retaining full responsibility for participant safety and the conduct of the trial at their site, supported rather than supplanted by our staff.

Experience

Twenty years of clinical trials, and a market that finally caught up.

Our team has been conducting clinical trial research for pharmaceutical and medical products for over twenty years, across dozens of studies and a range of indications. That work has spanned academic medical centres, community physician practices, and health systems — which is precisely the mix an SMO has to be able to operate in.

The market has moved toward this model rather than away from it. The global SMO market was valued at roughly $6.2 billion in 2023 and is projected to reach $9.5 billion by 2030. Dedicated site networks and SMOs hold the largest share of the investigative site market. Three out of four sponsors already use site networks, and 92% expect to use them for upcoming trials.

For a provider weighing whether research is a real opportunity, the underlying numbers are worth stating plainly. The US clinical trials market was valued at approximately $25.8 billion in 2023, and drug development programs routinely run from hundreds of millions of dollars into the billions. Sponsors are not short of studies. They are short of sites that execute.

Legal entity

Premier Bioservices, LLC
Established 2024

Corporate Headquarters

1029 Highway 51, Ste B #1034Madison, MS 39110

Contact

(601) 454-4479
Message us

Study locations

Managed across multiple network sites. Participant visits occur at network locations, remotely, or in the home.

Work with us

Whatever side of a study you are on, start with a conversation.

Sponsors, providers, health systems, and clinicians all reach us the same way. Tell us what you are trying to do.